Kura Oncology (KURA) News Today $8.25 +0.10 (+1.18%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$8.12 -0.13 (-1.59%) As of 02/21/2025 07:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Kura Oncology, Inc. (NASDAQ:KURA) Receives $27.13 Consensus Price Target from BrokeragesFebruary 21 at 1:47 AM | americanbankingnews.comKura Oncology to Report Fourth Quarter and Full Year 2024 Financial ResultsFebruary 19 at 7:30 AM | globenewswire.comKura Oncology (KURA) to Release Earnings on TuesdayKura Oncology (NASDAQ:KURA) will be releasing earnings before the market opens on Tuesday, February 25, Financial Modeling Prep reports.February 18, 2025 | marketbeat.comKura Oncology, Inc. (NASDAQ:KURA) Receives Average Rating of "Moderate Buy" from BrokeragesKura Oncology, Inc. (NASDAQ:KURA - Get Free Report) has received an average rating of "Moderate Buy" from the twelve ratings firms that are covering the stock, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation, eight have issued a buy recommendation andFebruary 18, 2025 | marketbeat.comKura Oncology's SWOT analysis: stock poised for pivotal year aheadFebruary 17, 2025 | msn.comLeerink Partnrs Comments on Kura Oncology Q1 EarningsFebruary 12, 2025 | americanbankingnews.comScotiabank Sticks to Its Buy Rating for Inmune Bio (INMB)February 11, 2025 | markets.businessinsider.comBarclays PLC Buys 84,563 Shares of Kura Oncology, Inc. (NASDAQ:KURA)Barclays PLC lifted its position in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 104.5% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 165,484 shares of the company's stock after purchasing an additional 84,563 shares during the quarterFebruary 11, 2025 | marketbeat.comAnalysts Set Expectations for Kura Oncology FY2029 EarningsKura Oncology, Inc. (NASDAQ:KURA - Free Report) - Stock analysts at Wedbush issued their FY2029 earnings estimates for shares of Kura Oncology in a research report issued to clients and investors on Thursday, February 6th. Wedbush analyst R. Driscoll anticipates that the company will earn $2.60 pFebruary 10, 2025 | marketbeat.comLeerink Partnrs Predicts Kura Oncology Q1 EarningsKura Oncology, Inc. (NASDAQ:KURA - Free Report) - Equities research analysts at Leerink Partnrs issued their Q1 2025 EPS estimates for shares of Kura Oncology in a report issued on Wednesday, February 5th. Leerink Partnrs analyst J. Chang forecasts that the company will post earnings per share ofFebruary 10, 2025 | marketbeat.comAnalysts Are Bullish on Top Healthcare Stocks: Zimmer Biomet Holdings (ZBH), Kura Oncology (KURA)February 8, 2025 | markets.businessinsider.comJennison Associates LLC Takes Position in Kura Oncology, Inc. (NASDAQ:KURA)Jennison Associates LLC acquired a new stake in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm acquired 71,497 shares of the company's stock, valued at approximately $623,000. Jennison Associates LLC oFebruary 8, 2025 | marketbeat.comKura Oncology reports inducement grants under Nasdaq listing ruleFebruary 7, 2025 | markets.businessinsider.comKura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)February 7, 2025 | globenewswire.comLeerink Partnrs Weighs in on Kura Oncology Q2 EarningsKura Oncology, Inc. (NASDAQ:KURA - Free Report) - Analysts at Leerink Partnrs issued their Q2 2025 earnings per share estimates for shares of Kura Oncology in a report released on Wednesday, February 5th. Leerink Partnrs analyst J. Chang anticipates that the company will earn $0.14 per share forFebruary 7, 2025 | marketbeat.comBTIG cuts Kura Oncology stock rating to NeutralFebruary 6, 2025 | msn.comKura Oncology stock target raised to $40 by H.C. WainwrightFebruary 6, 2025 | msn.comKura Oncology price target raised to $36 from $34 at WedbushFebruary 6, 2025 | markets.businessinsider.comKura Oncology (NASDAQ:KURA) Shares Gap Down - Here's WhyKura Oncology (NASDAQ:KURA) Shares Gap Down - Here's WhyFebruary 6, 2025 | marketbeat.comKura Oncology Cancer Study Hits Primary Goal, Lays Out Plans For Phase 3 StudiesFebruary 6, 2025 | benzinga.comKura Oncology's (KURA) Market Outperform Rating Reiterated at JMP SecuritiesJMP Securities reiterated a "market outperform" rating and issued a $28.00 price target on shares of Kura Oncology in a research report on Thursday.February 6, 2025 | marketbeat.comWedbush Increases Kura Oncology (NASDAQ:KURA) Price Target to $36.00Wedbush lifted their price target on shares of Kura Oncology from $34.00 to $36.00 and gave the company an "outperform" rating in a research note on Thursday.February 6, 2025 | marketbeat.comKura Oncology (NASDAQ:KURA) Stock Price Expected to Rise, HC Wainwright Analyst SaysHC Wainwright lifted their price target on Kura Oncology from $37.00 to $40.00 and gave the company a "buy" rating in a research report on Thursday.February 6, 2025 | marketbeat.comKura Oncology (NASDAQ:KURA) Lowered to Neutral Rating by BTIG ResearchBTIG Research cut Kura Oncology from a "buy" rating to a "neutral" rating in a report on Thursday.February 6, 2025 | marketbeat.comKura stock slides 7% following ziftomenib updateFebruary 5, 2025 | msn.comKura Oncology and Kyowa Kirin Announce Positive Ziftomenib Monotherapy Registrational Trial and Positive FDA Feedback for Upcoming Frontline Combination Trial DesignsFebruary 5, 2025 | globenewswire.comScotiabank Sticks to Its Hold Rating for Kura Oncology (KURA)February 5, 2025 | markets.businessinsider.comKura Oncology (NASDAQ:KURA) Shares Up 6.7% - Time to Buy?Kura Oncology (NASDAQ:KURA) Shares Up 6.7% - Time to Buy?February 3, 2025 | marketbeat.comSG Americas Securities LLC Takes $436,000 Position in Kura Oncology, Inc. (NASDAQ:KURA)SG Americas Securities LLC bought a new stake in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 50,039 shares of the company's stock, valued at approxFebruary 3, 2025 | marketbeat.comStifel Nicolaus Keeps Their Buy Rating on Syndax Pharmaceuticals (SNDX)February 1, 2025 | markets.businessinsider.comMoody Aldrich Partners LLC Has $1.25 Million Stock Position in Kura Oncology, Inc. (NASDAQ:KURA)Moody Aldrich Partners LLC raised its stake in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 42.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 143,587 shares of the company's stock after buying an additionalJanuary 29, 2025 | marketbeat.comKura Oncology's finance SVP sells shares worth $38,958January 29, 2025 | msn.comKura Oncology's chief scientific officer sells $17,050 in stockJanuary 29, 2025 | msn.comKura Oncology, Inc. (NASDAQ:KURA) COO Kathleen Ford Sells 1,817 SharesKura Oncology, Inc. (NASDAQ:KURA - Get Free Report) COO Kathleen Ford sold 1,817 shares of the company's stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $7.87, for a total value of $14,299.79. Following the completion of the transaction, the chief operating officer now owns 21,367 shares in the company, valued at approximately $168,158.29. The trade was a 7.84 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.January 28, 2025 | marketbeat.comKura Oncology, Inc. (NASDAQ:KURA) SVP Sells $38,948.63 in StockKura Oncology, Inc. (NASDAQ:KURA - Get Free Report) SVP Thomas James Doyle sold 4,949 shares of the stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $7.87, for a total value of $38,948.63. Following the transaction, the senior vice president now directly owns 88,193 shares in the company, valued at approximately $694,078.91. The trade was a 5.31 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.January 28, 2025 | marketbeat.comMollie Leoni Sells 4,963 Shares of Kura Oncology, Inc. (NASDAQ:KURA) StockKura Oncology, Inc. (NASDAQ:KURA - Get Free Report) insider Mollie Leoni sold 4,963 shares of Kura Oncology stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $7.87, for a total transaction of $39,058.81. Following the sale, the insider now owns 88,253 shares of the company's stock, valued at $694,551.11. The trade was a 5.32 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.January 28, 2025 | marketbeat.comStifel Nicolaus Sticks to Its Hold Rating for ALX Oncology Holdings (ALXO)January 24, 2025 | markets.businessinsider.comKura Oncology (KURA) Gets a Buy from JefferiesJanuary 24, 2025 | markets.businessinsider.comKura Oncology, Inc. (NASDAQ:KURA) Given Consensus Recommendation of "Moderate Buy" by BrokeragesKura Oncology, Inc. (NASDAQ:KURA - Get Free Report) has received a consensus rating of "Moderate Buy" from the eleven analysts that are currently covering the company, Marketbeat reports. Two analysts have rated the stock with a hold recommendation, eight have issued a buy recommendation and oneJanuary 24, 2025 | marketbeat.comReplimune Group’s Promising Outlook: FDA Priority Review and Positive Trial Data Support Buy RatingJanuary 23, 2025 | markets.businessinsider.comCantor Fitzgerald Weighs in on Kura Oncology FY2025 EarningsKura Oncology, Inc. (NASDAQ:KURA - Free Report) - Research analysts at Cantor Fitzgerald issued their FY2025 earnings estimates for Kura Oncology in a research note issued on Tuesday, January 21st. Cantor Fitzgerald analyst L. Watsek forecasts that the company will earn ($2.94) per share for theJanuary 22, 2025 | marketbeat.comAssenagon Asset Management S.A. Sells 146,879 Shares of Kura Oncology, Inc. (NASDAQ:KURA)Assenagon Asset Management S.A. decreased its holdings in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 14.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 905,184 shares of the company's stock after seJanuary 20, 2025 | marketbeat.comKura Oncology, Inc. (NASDAQ:KURA) Sees Large Growth in Short InterestKura Oncology, Inc. (NASDAQ:KURA - Get Free Report) was the recipient of a large increase in short interest in the month of December. As of December 31st, there was short interest totalling 10,440,000 shares, an increase of 17.4% from the December 15th total of 8,890,000 shares. Approximately 16.0% of the company's shares are sold short. Based on an average trading volume of 1,660,000 shares, the days-to-cover ratio is currently 6.3 days.January 19, 2025 | marketbeat.comKura Oncology (NASDAQ:KURA) Hits New 52-Week Low - What's Next?Kura Oncology (NASDAQ:KURA) Sets New 1-Year Low - Here's What HappenedJanuary 13, 2025 | marketbeat.comBrookline Capital Management Predicts Kura Oncology FY2029 EarningsKura Oncology, Inc. (NASDAQ:KURA - Free Report) - Equities research analysts at Brookline Capital Management issued their FY2029 earnings estimates for Kura Oncology in a report issued on Monday, January 6th. Brookline Capital Management analyst L. Cann anticipates that the company will earn $12.January 9, 2025 | marketbeat.comKura Oncology price target lowered to $10 from $18 at ScotiabankJanuary 8, 2025 | markets.businessinsider.comKura Oncology (NASDAQ:KURA) Price Target Cut to $10.00 by Analysts at ScotiabankScotiabank lowered their price target on Kura Oncology from $18.00 to $10.00 and set a "sector perform" rating on the stock in a research report on Wednesday.January 8, 2025 | marketbeat.comKura Oncology (NASDAQ:KURA) Sets New 1-Year Low - Time to Sell?Kura Oncology (NASDAQ:KURA) Sets New 52-Week Low - What's Next?January 7, 2025 | marketbeat.comKura Oncology Promotes New Chief Medical OfficerJanuary 7, 2025 | marketwatch.comKura Oncology Announces Leadership Changes and AppointmentsJanuary 7, 2025 | msn.com Get Kura Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for KURA and its competitors with MarketBeat's FREE daily newsletter. Email Address KURA Media Mentions By Week KURA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KURA News Sentiment▼0.300.61▲Average Medical News Sentiment KURA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KURA Articles This Week▼55▲KURA Articles Average Week Get Kura Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for KURA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies IBRX News ARWR News HCM News EWTX News MIRM News AMRX News KYMR News GMTX News PTGX News MESO News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KURA) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | Sponsored2025 AI Blueprint features Nvidia’s march to $5 trillionNvidia is now one of the most valuable companies in the world. It currently ranks second, just behind Apple...Weiss Ratings | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredHas Trump finally met his match?A new Chinese AI software called "DeepSeek" is sending shockwaves through the market. It's advanced enough ...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kura Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kura Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
